Skip to main content
Thorax logoLink to Thorax
. 1993 Apr;48(4):401. doi: 10.1136/thx.48.4.401

Treatment of resistant pain in hypertrophic pulmonary arthropathy with ketorolac.

N Blackwell 1, L Bangham 1, M Hughes 1, D Melzack 1, I Trotman 1
PMCID: PMC464442  PMID: 8511741

Abstract

Pain associated with hypertrophic pulmonary osteoarthropathy (HPOA) may be extremely disabling and resistant to treatment. The successful use of ketorolac, a new non-steroidal anti-inflammatory drug, given by subcutaneous infusion is reported in two patients with uncontrolled pain caused by HPOA.

Full text

PDF

Page 401

401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buckley M. M., Brogden R. N. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 1990 Jan;39(1):86–109. doi: 10.2165/00003495-199039010-00008. [DOI] [PubMed] [Google Scholar]
  2. Davies R. A., Darby M., Richards M. A. Hypertrophic pulmonary osteoarthropathy in pulmonary metastatic disease. A case report and review of the literature. Clin Radiol. 1991 Apr;43(4):268–271. doi: 10.1016/s0009-9260(05)80254-5. [DOI] [PubMed] [Google Scholar]
  3. Litvak K. M., McEvoy G. K. Ketorolac, an injectable nonnarcotic analgesic. Clin Pharm. 1990 Dec;9(12):921–935. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES